Dr. Dickson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Childrens Pl
# Div
Saint Louis, MO 63110Phone+1 314-454-6093Fax+1 844-965-9624
Education & Training
- Cedars-Sinai Medical CenterResidency, Medical Genetics and Genomics, 2003 - 2007
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 1999 - 2003
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1999, MD
Certifications & Licensure
- IL State Medical License 2021 - 2026
- MO State Medical License 2018 - 2025
- CA State Medical License 2000 - 2020
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Medical Genetics and Genomics Medical Biochemical Genetics
- American Board of Pediatrics Pediatrics
Clinical Trials
- Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I Start of enrollment: 2005 Nov 01
- Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I Start of enrollment: 2008 Jan 01
- A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.Joseph Muenzer, Carole Ho, Heather Lau, Mark Dant, Maria Fuller
Molecular Genetics and Metabolism. 2024-08-01 - 2 citationsD-mannose as a new therapy for fucokinase deficiency-related congenital disorder of glycosylation (FCSK-CDG).Rodrigo Tzovenos Starosta, Angela J Lee, Elizabeth R Toolan, Miao He, Parith Wongkittichote
Molecular Genetics and Metabolism. 2024-06-01 - Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I.Sarah C Hurt, Moin U Vera, Steven Q Le, Shih-Hsin Kan, Quang Bui
Molecular Genetics and Metabolism Reports. 2024-03-01
Press Mentions
- Yes, Men Can Get Breast Cancer, Too. Here’s Who Is Most at RiskOctober 31st, 2022
- Men Urged to Get Tested for Gene That Causes Breast CancerJuly 8th, 2022
- Sanfilippo B Enzyme Replacement Therapy M041 Can Get into CellsAugust 19th, 2021
- Join now to see all
Grant Support
- Intrathecal Enzyme Therapy For Mucopolysaccharidosis INational Institute Of Neurological Disorders And Stroke2006–2010
- Pilot/Phase I Study Of Intrathecal Laronidase For Spinal Cord Compression In MucoFood And Drug Administration2008–2009
- A Study Of Intrathecal Enzyme Replacement Therapy For Spinal Cord CompressionNational Center For Research Resources2006–2009
- Clinical Trial: A Study Of Intrathecal Enzyme Replacement Therapy For Spinal CORNational Center For Research Resources2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: